Literature DB >> 19321667

Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase.

David Vaught1, Jin Chen, Dana M Brantley-Sieders.   

Abstract

Eph receptor tyrosine kinases, including EphA2, are expressed in the mammary gland. However, their role in mammary gland development remains poorly understood. Using EphA2-deficient animals, we demonstrate for the first time that EphA2 receptor function is required for mammary epithelial growth and branching morphogenesis. Loss of EphA2 decreased penetration of mammary epithelium into fat pad, reduced epithelial proliferation, and inhibited epithelial branching. These defects appear to be intrinsic to loss of EphA2 in epithelium, as transplantation of EphA2-deficient mammary tissue into wild-type recipient stroma recapitulated these defects. In addition, HGF-induced mammary epithelial branching morphogenesis was significantly reduced in EphA2-deficient cells relative to wild-type cells, which correlated with elevated basal RhoA activity. Moreover, inhibition of ROCK kinase activity in EphA2-deficient mammary epithelium rescued branching defects in primary three-dimensional cultures. These results suggest that EphA2 receptor acts as a positive regulator in mammary gland development, functioning downstream of HGF to regulate branching through inhibition of RhoA. Together, these data demonstrate a positive role for EphA2 during normal mammary epithelial proliferation and branching morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321667      PMCID: PMC2682598          DOI: 10.1091/mbc.e08-04-0378

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  34 in total

Review 1.  Rho family proteins: coordinating cell responses.

Authors:  A J Ridley
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

2.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

3.  P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer.

Authors:  G Chakravarty; D Roy; M Gonzales; J Gay; A Contreras; J M Rosen
Journal:  Cell Growth Differ       Date:  2000-07

Review 4.  Eph receptor signalling casts a wide net on cell behaviour.

Authors:  Elena B Pasquale
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

Review 5.  Information networks in the mammary gland.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Nat Rev Mol Cell Biol       Date:  2005-09       Impact factor: 94.444

6.  Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.

Authors:  Dana M Brantley-Sieders; Wei Bin Fang; Donna J Hicks; Guanglei Zhuang; Yu Shyr; Jin Chen
Journal:  FASEB J       Date:  2005-09-15       Impact factor: 5.191

Review 7.  EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Authors:  Reneé C Ireton; Jin Chen
Journal:  Curr Cancer Drug Targets       Date:  2005-05       Impact factor: 3.428

8.  A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Monica A Parker; Alastair D Reith; Jin Chen
Journal:  Oncogene       Date:  2005-11-24       Impact factor: 9.867

Review 9.  Rho GTPases and cell migration.

Authors:  A J Ridley
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

Review 10.  Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis.

Authors:  J W Pollard
Journal:  Breast Cancer Res       Date:  2001-06-14       Impact factor: 6.466

View more
  36 in total

Review 1.  Spatial organization of transmembrane receptor signalling.

Authors:  Ioanna Bethani; Sigrid S Skånland; Ivan Dikic; Amparo Acker-Palmer
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

Review 2.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

Review 3.  Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.

Authors:  Gwyndolen C Harburg; Lindsay Hinck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-05       Impact factor: 2.673

Review 4.  Integrated morphodynamic signalling of the mammary gland.

Authors:  Nikolce Gjorevski; Celeste M Nelson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-10       Impact factor: 94.444

5.  Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype.

Authors:  Ramray Bhat; Mina J Bissell
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2014

Review 6.  Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair.

Authors:  Polina Goichberg
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

7.  JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.

Authors:  Wenqiang Song; Yufang Ma; Jialiang Wang; Dana Brantley-Sieders; Jin Chen
Journal:  Cancer Res       Date:  2014-03-07       Impact factor: 12.701

Review 8.  Non-SH2/PDZ reverse signaling by ephrins.

Authors:  Ira O Daar
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

9.  p120-catenin is essential for terminal end bud function and mammary morphogenesis.

Authors:  Sarah J Kurley; Brian Bierie; Robert H Carnahan; Nichole A Lobdell; Michael A Davis; Ilse Hofmann; Harold L Moses; William J Muller; Albert B Reynolds
Journal:  Development       Date:  2012-03-29       Impact factor: 6.868

Review 10.  Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

Authors:  Jacqueline Whyte; Orla Bergin; Alessandro Bianchi; Sara McNally; Finian Martin
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.